A NumPy stationary bootstrap with a seed of 20260905 was used to analyze 10,000 paths of 27 trading sessions from the net 10-month portfolio daily returns from 2023-2026-09-04, with a mean block of 20 sessions. The data source is https://runway.adityaperswal.workers.dev/data/stock-bars. The conditional returns for the 5th, 50th, and 95th percentiles were -2.7595%, +1.0247%, and +3.8952%, respectively. The probability of loss was 32.42%, and the 95th-percentile path maximum drawdown was 4.4290%. For a hypothetical full fund of $245.69, these returns imply -6.78, +2.52, and +9.57 dollars before operating overhead. None of the simulated paths resulted in a return of $348.92, but this does not prove that the true probability of this return is zero. The 27 sessions used in the simulation are longer than the 27 calendar days remaining and should not be used as a month-end forecast. The historical blocks used in the simulation omit unseen gaps and do not account for current holdings, which are actually cash. This model estimates variability based on resampled past exposure, not today's executable stop or target success. The conclusion is that funding pressure cannot justify sizing, and the simulation gives no live entry odds. A binary trade-payoff heuristic of quarter * (p - (1-p) / (avg win / avg loss)) = 0.0620 is a risk-fraction heuristic, but unequal continuous returns, overlapping trades, and unmodeled exits prevent translating it into dollar allocation. The Quarter-Kelly for the actual venue rule remains unavailable, and the policy size is 0. It is possible that a new trend could outperform all these paths, but there is no measured probability to support betting on it.
A broader bottleneck screen shows that contract structure determines who captures scarcity. The first premise is based on Micron's FY26Q3 10-Q report, which explicitly states that allocation is under supply constraints, but largest strategic contracts generally cap existing-product prices near calendar Q2. This means that take-or-pay contracts protect volume and floor economics, but not unlimited upside. The FY25 10-K report adds that there is a risk of single-source lithography and 17% revenue comes from one unnamed customer. The strongest bear argument is that customer capital expenditure slows while upstream equipment and capacity spending stays committed, but a counterexample is binding multi-year demand. The second premise is based on GEV's Q2 electrification orders and revenue, which imply a book-to-bill of 1.745 and an EBITDA margin of 18.4%. This suggests that supplier economics are being realized. However, the FY25 risk factors disclose constrained critical inputs and delivery penalties. It is rejected that all backlog is freely cancelable, as RPO excludes orders that are cancelable without substantive penalty. The third premise is based on Murata's July 31 forecast, which sees capacitor revenue increasing by 23.6% and consolidated revenue increasing by 15.2%, with capital expenditure increasing by 2.9%. This shows that server and distributor demand strength coexists with weakness elsewhere, so broad component-shortage claims lack part-level proof. The fourth premise is based on Hapag's $600/container Conosur GRI, which takes effect on September 4, but the announcement does not prove realized yield or port congestion. The sources of this information are respectively https://www.sec.gov/Archives/edgar/data/723125/000072312526000015/mu-20260528.htm, https://www.sec.gov/Archives/edgar/data/723125/000072312525000028/mu-20250828.htm, https://www.sec.gov/Archives/edgar/data/1996810/000199681026000147/gevpressrelease2q26.htm, https://www.gevernova.com/sites/default/files/gevernova_2025_form10-k.pdf, https://corporate.murata.com/en-us/ir/financial/forecast, and https://www.hapag-lloyd.com/zh/services-information/news/2026/07/shipping-with-our-conosur-service--con---a-gri-is-coming-up.headless.html. The information was read on September 5, and the issuer claims to be interested, but the filing and report dates differ, with no contradiction from timing. The consequences inferred are that scarce capacity transfers cash from buyers to qualified suppliers, caps, floors, cancellations, and upstream shortages determine retained margin, and capacity investment and substitution can normalize rents before volumes peak. The binding constraint is incremental unpriced evidence and a validated stock rule. The conclusion is to watch only, with no new fund warranted, as these are already within the Supply mandate. Missing information includes part-level lead times, independent actual shipping flows, normalized valuation, non-US venue eligibility, and out-of-stock rules for new names. Legacy coverage is not used as corroboration.
A news scan found the headline is not available, but a report on global trend holdout uncertainty and beta was released. The report discusses defense without demonstrated alpha. It mentions SIP-derived 2023-2026-09-04 fixed 10-month returns, which came from https://runway.adityaperswal.workers.dev/data/stock-bars. The report states that 18 closed trades had an average return of +2.3818%. A bootstrap analysis, which is a statistical method to estimate uncertainty, was done with 20,000 repetitions and a seed of 20260905. The mean return was between -1.1377% and 6.3696% with 95% confidence. About 10.375% of the draws were nonpositive. The report notes that trades overlap across correlated markets, so the interval is only diagnostic. If the best trade, which had a return of +24.5168%, is removed, the mean return falls to +1.0797%. A joint stationary block bootstrap, which is another statistical method, was done with 20 sessions and 3,000 full-horizon paths. The annual arithmetic strategy mean return was between 1.8463% and 13.6657%. The active versus benchmark return was between -9.7113% and -0.7710%. The report states that this is conditional resampling of one history, not a population confidence guarantee. A daily ordinary least squares analysis, which is a statistical method to model the relationship between variables, was done versus an equal-initial-sleeve buy-hold. The beta, which measures volatility, was 0.6631, and the annualized intercept was -0.7287%. The R2, which measures the goodness of fit, was 0.7887. The report notes that this is descriptive, not causal, and does not imply alpha, which refers to excess return. The daily correlation between SPY and EFA was 0.7598, and between SPY and IEF was 0.0528 in the test period, versus 0.1931 in 2022. The report gives a counterexample, stating that observed lower drawdown can follow reduced exposure alone, and a different crisis may break diversification. The validity of the report is limited by the small number of trades, and the soundness is limited by the selected asset-class wrapper set and missing 2008 data. The report preserves the 10-month rule and does not select 12 months after looking. The policy allocation is 0.
The fund manager preregistered notes 88 out of 94 before returns. A February 2013 paper by Faber, found at https://mebfaber.com/wp-content/uploads/2016/05/SSRN-id962461.pdf, supports the idea that the monthly close should be above the 10-month Simple Moving Average, a calculation that shows the average price of a security over a certain period. Our adaptation uses Exchange-Traded Funds, or ETFs, which are traded on an exchange like stocks, and follows the session open, with five equal and independent cash sleeves, or portions of the portfolio, that drift, or change, based on dividend-adjusted prices and zero cash yield, which means no interest is earned on cash holdings. Published index exposures and same-close/cash assumptions differ. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars, with a Systematic Investment Plan, or SIP, adjustment of all, and 2684 common sessions from 2016-01-04 to 2026-09-04. The requested data from 2007 was unavailable, and there was no 2008 test. The development period from 2017 showed a return of +8.94%, the validation period from 2018 to 2022 showed a return of +18.31%, with a maximum drawdown, or loss, of 8.11%, and 26 closed trades. The chronological test from 2023 to 2026-09-04 showed a return of +31.22%, with a Compound Annual Growth Rate, or CAGR, of 7.69%, a maximum drawdown of 6.85%, and 18 closed trades, with 44.44% wins, an average win of 9.60%, and an average loss of -3.40%, with 4 open positions. A buy-hold test, which means holding the investment without making any changes, showed a return of +56.39%, with a maximum drawdown of 11.31%. The portfolio includes marked open positions, but trade statistics exclude them. Costs include a 5 basis point, or 0.05%, fee, plus 5 basis points of slippage, or the difference between the expected and actual price of a trade, each side, and underlying ETF expenses are embedded, but taxes, operating overhead, and terminal liquidation cost on open positions are excluded. A fixed 8 and 12 month test showed returns of +30.35% and +36.07%, which are for diagnostic purposes only. A 25 and 50 basis point one-way test showed returns of +29.74% and +27.33%. An independent cash and share ledger matches the main vectorbt equity within 4.55e-13 dollars on 1000 initial. A counterexample is that gains do not prove alpha, or superior performance, and slow winners and beta, or the measure of volatility, explain much of the performance. The median hold is 182.5 calendar days, and there is no mandatory stop, target, profit-taking, or 15-minute fill model, and no fractional idealized sizing, or adjusting the size of the trade, and no cash-payout reinvestment timing. The conclusion is to WATCH the research, but not to ADOPT it, as all windows have been inspected, and adaptations require independent prospective evidence.
A news scan found the notes of an automated trading fund manager. The manager has no open holdings or queued orders and no stops or targets to adjust. The manager thinks that Frontline, or FRO, a company that owns tankers, may not do well because when things return to normal, there will be more tankers available, and if there are problems, cargo can be destroyed and uninsured costs can rise. The manager notes that the money made from loading and unloading cargo does not include the cost of sailing without cargo, which is called ballast. The manager also thinks that lower earnings and delivery commitments can reduce the amount of money that can be distributed to shareholders. Additionally, lower expected distributions and vessel values can decrease the value of the company's stock before the company gives guidance. However, the manager notes that if companies rebuild their stockpiles or use longer routes, and have fixed charters, this could help the company's earnings. The manager read an attachment that showed one charter with payments of 110,000, 70,000, and 45,000 over three years, which limits the upside of that ship without proving that the spot market will collapse. The manager also thinks that Scorpio Tankers, or STNG, may not do well because new fixed contracts trade upside for certainty, with two LR2 rates averaging 41,344 per day, which is a 36.3% discount compared to the current spot rate of 64,900 per day. The manager notes that locked revenue cushions spot weakness but caps those ships, and that product volume contraction and counterparty risk can offset rerouting gains. The manager also notes that fleet growth and lower marginal freight can reprice residual spot earnings. However, the manager notes that these are just two of 25 owned LR2s, and that guaranteed term income can increase value. The manager found that the correlation between FRO and STNG is 0.751 over 420 observations, which weakens the original diversification premise. The manager notes that these channels challenge assumptions about pricing power, but do not establish near-term negative returns. The manager's sources include Frontline's second-quarter and six-months 2026 results, a press release from Scorpio Tankers, and filings from the Securities and Exchange Commission. The manager notes that the issuer dates are August 28 and September 3, and that the filings are for FY2025, and that there were no new announcements on September 4. The manager notes that the price of the stocks crossed prior 20 closing highs on September 4, but that price strength does not resolve implementation or uncertainty. The manager starts with cash and aims for repeatable returns, with a binding constraint of a robust tested payoff distribution.
The analysis is looking at three biotech companies, RARE, IONS, and MIRM, to identify potential risks and countercases. For RARE, the issuer confirmed on September 2 that the primary and secondary Aspire trials missed their targets, which could lead to a lower expected value of GTX102, possible expense reductions, and execution disruption. However, the strongest countercase is that the commercial medicines and potential UX111 value could still survive. For IONS, the issuer confirmed on September 4 that the pelacarsen outcomes trial failed, despite biomarker lowering, which could lead to reduced program revenue and royalty expectations, and a re-evaluation of biomarker-to-outcome assumptions. The countercase is that approved zilganersen and other programs remain distinct. For MIRM, the primary result had a p-value of 0.0986, and there is an overlap with the AZURE1 Q3 trial, which could lead to regulatory or readout surprises, launch and royalty timing affects, and greater spend or delay. The countercase is that secondary efficacy and rare-disease unmet need may support FDA judgment. The analysis is based on qualitative hypotheses and not measured causal effects, with a starting cash position of $49.14 and a goal of reproducible net gains. There are binding constraints, including complete dated inventories, uncertain overlapping events, and numerical strategy edge. No new company-wide IONS inventory was completed, and existing rejection remains. Regulatory outcomes can benefit patients and sponsors commercially, but unsupported turnover benefits liquidity providers. A zero size position does not assert a zero probability of rallies.
A news scan found the headline about MIRM's bear case. The case is based on two main points. Firstly, on June 14, the joint issuer released information about a study called PROGRESS, which showed that a new treatment had a primary result with a probability value of 0.0986, which is not considered statistically significant, and a secondary result with a probability value of less than 0.0001, indicating a reduction of more than 99% in new lesion volume. This means that the previous claims of a clean clinical success were overstated because they did not consider the hierarchy of the results. Secondly, on August 5, the issuer reported that the FDA recommended moving forward with a separate treatment called volixibat, despite the results of a study called VISTAS, and that the potential filing for this treatment could now happen in the first half of 2027, which overlaps with the expected decision date for another treatment called zilurgisertib on September 26. The company also reported revenue of $176.2 million versus expenses of $218.8 million, resulting in an accounting operating gap of $42.6 million, but this does not necessarily mean the company is burning cash, as it has $561.3 million in cash after receiving $690 million in new investments and a $237.2 million settlement. A strong counterargument is that the growth of a treatment called LIVMARLI and the secondary efficacy of zilurgisertib could still support approval and commercial value. The validity of the bear case is based on unresolved overlapping binary risk, which violates the clean-run-up entry rule. The soundness of the case is based on primary source dates, but no probability or valuation model has been established. The goal is to validate pre-event expectancy, considering binding constraints and affordable whole shares. Commercial beneficiaries could include Mirum and Incyte via licensing economics, but risks remain shared by equity holders. There is no current holding or adjustment. The sources of this information are the company's news releases on June 14 and August 5, which can be found on the company's website. These findings are new for our audit, but they are not new news announced today.
A September 5 nightly review of the quant fund's trades confirmed that all three lots were closed on September 4 through operator liquidation, resulting in zero holdings, pending orders, or monitors. The strongest bear case against the former shared thesis is that buying a stock with a large positive earnings gap can be based on already-priced information and exhaustion, rather than residual drift. A saved analysis, holdout #10, lost 30.23% over 20 sessions, but was not rerun or audited due to missing original artifacts. The performance of certain stocks, such as DELL's +7.94% gain, GTLB's -5.13% loss, and SNOW's -5.39% loss, cannot validate 4-6 week exits. The conclusion is that old re-entry instructions remain superseded, and there are no stops or targets to reset. The validity of this conclusion is limited by the lack of eligible tested edge and missing artifacts. A qualitative chain of events suggests that certain stocks may experience reversals due to various factors, but these are counterfactual stress paths, not newly verified company fundamentals. The change today is book liquidation, not a newly measured fundamental deterioration. The starting cash position is $245.69, with the goal of finding a reproducible edge. The source ledger and saved analysis #10, as well as prior research from https://arxiv.org/abs/2601.08962, support this conclusion. Spread recipients may benefit from unsupported re-entry.
A review of the current trading situation was done using a technical lesson. The current watchlist, number 20, is still more important than the adopt list, number 5. There are three main points to consider. First, the fund's memory does not have any new daily or hourly data about costs or profits. Second, the main ledger shows that all Bitcoin, ticker BTC, positions were closed, and there are no open or pending positions. Third, new data from September 3 shows that the signal for Bitcoin and Uniswap, ticker UNI, is true, but not strong enough to take action. The conclusion is to keep $235.86 in cash and not make any changes. The reason for this is that there is not enough valid data to make a decision. The current strategy has limits, including no new data, no verified top-volume ranking, and no new quotes or catalysts. The goal is to have a repeatable positive return. The Quarter-Kelly strategy is not defined, and the policy allocation is $0. Premature turnover can hurt the fund, and no new tests are needed at this time. The official documentation for cryptocurrency bars was checked, and the existing watch output was truncated. A new script was tested, and a replacement is scheduled for 240 minutes from now. The next research should include daily and hourly validation with prospective holdout and attainable exits, and should start on September 5 at 00:00 UTC.
A review of the trading system was conducted at 21:18. The system retains its cash position because no validated trading opportunity, or edge, was found. The system looks at past trades, including 3 trades with a return of -2.45%, to decide what to do. A win rate of 33.3% was recorded, but this is not a reliable estimate of future performance. The system also looks at the history of stocks like ADBE and GME, but their past gains do not change the decision to retain cash. The system has no active trades and no pending trades. The Kroger company, whose stock is ticker KR, announced a conference call for September 11 at 08:00 ET, but this does not affect the decision to retain cash. The system will keep its cash position at $49.14. The decision is based on the lack of a validated trading edge, which means there is no reliable way to make a profit. The system will continue to look for a repeatable way to make a profit, but for now, it will not make any trades. The next review will be on September 5 at 00:00 UTC.
The existing research trading review found that the current supply strategy, number 19, is still the latest one. This strategy does not allow for re-entry because there is no reliable way to measure the cost of entering and exiting the market in a timely manner. The live trade ledger only shows two closed trades that were liquidated by the operator, and there are no pending or open trades. These trades do not provide enough information to estimate the natural payoff distribution or validate stops and targets. The issuer of Frontline Plc reopened its website with second-quarter and six-months 2026 results, which still shows strong booked rates and ballast-day qualification, but this does not provide any new independent evidence. As a result, the decision is to retain $278.67 in cash and make no new entries, exits, or adjustments. The validity of this decision is limited by the lack of a numerical edge, which means there is no eligible size. The soundness of this decision is also bounded by unreviewed historical data and the absence of a broad fresh-news scan. This does not mean that tanker stocks will fall, and strong rates could support further gains. However, this does not provide a clear expected win/loss or attainable exits. The goal is to start flat and achieve repeatable positive net returns, with the constraint of audited implementation and out-of-sample calibration. The Quarter-Kelly criterion is undefined, and the policy notional is zero. The consequence chain is that freight scarcity can favor owners over charterers, and ballast and utilization can alter realized earnings. Equity gains further depend on valuation and entry/exit timing. No new backtest, statistical fit, or Monte Carlo run was done because no new rule was proposed, and the assumed payoff inputs would not repair the missing evidence. No new signal or exposure needs a new monitor or job before September 5 00:00 UTC research. The sources of this information include the query research, query trades, list monitors, and the supplied account snapshot, as well as the issuer's URL. Prior automatic-buy notes are no longer valid.
A trading review was done at 21:18. The decision was made to keep the current plan and not make any changes to the rejected Post-Earnings Announcement Drift, or PEAD, strategy. This means the fund will retain its cash. The review was based on three main points. First, the fund's memory of past trades and analyses did not have any rules that could be used to make trades after strategy number 17. Some old notes, numbers 4 and 7, are not being used. Second, a past test of the strategy, called backtest number 10, showed that it did not work well. The test found that the strategy would have lost 30.23% over 20 sessions and 6.38% over 5 sessions. The review also looked at the current state of the fund and found that there were no active or pending trades and no monitors. Three trades that were closed were studied to learn from them. The decision was made to keep $245.69 in cash and not make any trades. This is because the fund's rules require that any trade have a positive expected outcome, which is not the case here. There are also limits to how much the fund can trade, and these limits were not met. Some examples, such as DELL's forced gain, do not support the planned strategy. The fund will start the next period with no trades and the goal of making repeatable net gains. The fund's rules require that any strategy be tested and validated before it can be used. A study from https://arxiv.org/abs/2601.08962 was reviewed, but it does not support the fund's strategy. The fund will not make any trades until at least September 5 00:00 UTC, when the next research is scheduled.
A news scan found the headline 'CIO status resolution: Donchian-20 downgraded to WATCH; zero executable allocation'. The Chief Investment Officer, or CIO, has made a status resolution request. On September 2, a backtest, which is a test of a trading strategy using historical data, numbered 5 had a verdict of ADOPT, but this has been superseded by a verdict of WATCH for all live trading, consistent with an analysis numbered 15 from September 4. The historical reported returns are only being used as exploratory evidence. There are four premises for this decision. Premise 1 is that the source code for the backtest has been audited and confirms that it used the correct rules for entering and exiting trades. Premise 2 is that the backtest did not use independent chronological holdouts, which are sets of data used to test a strategy, and did not validate the strategy on an hourly basis. Premise 3 is that the live ledger, which is a record of all trades, has had one forced liquidation of Bitcoin, or BTC, and no open or pending trades, so it is not possible to determine the average win or loss. Premise 4 is that the data from the primary venue on September 4 at 21:06 UTC shows that the prices of BTC, ETH, SOL, and UNI are below their next-close thresholds. The conclusion is that no new trades will be entered, and the allocation of funds will be $0. The strongest counterargument is that the historical returns of BTC and SOL could reflect real momentum, but this does not fix the problems with the backtest. The validity of the strategy is uncertain because the required validation is missing. The soundness of the strategy has been directly inspected, but the raw data from old experiments is not available. The goal is to have positive net repeatable returns, and the binding constraint is that the strategy must be validated using realistic exits. The official documentation supports the use of hour bars, but the command-line interface only supports daily bars. If trades are made prematurely, counterparties will receive spreads, which are the differences between the prices at which trades are made. No new backtest or simulation was performed because this is a review of an unchanged trading rule. Remaining research includes designing independent holdouts, measuring costs and slippage, and testing weekend stress.
A review of existing research was done. The first point is that the current research returns a saved strategy, number 13, and six supply lessons. The old statement in number 13 was historical, not a current failure. No test results were found in the returned analyses. A search of files did not recover any missing test results. This is limited evidence, not proof that no results exist. The second point is that a search of trades confirms only two closed lots, FRO number 6 and STNG number 3, and a list of monitors confirms number 4 is done. Two wins cannot establish average loss or validate the original exits. The third point is that a release from Frontline on August 28 reports strong contracted rates, but expects lower full-quarter rates due to ballast days. The conclusion is to retain $278.67 cash and propose no entry, exit, or adjustment. This decision is valid because there is no numerical validated edge. The strongest counterexample is that rate strength could generate further equity gains. The goal is positive repeatable net returns, with a constraint of reproducible cost-inclusive chronological entry/exit calibration. The Quarter-Kelly method is undefined with available evidence. Shipowners may retain freight pricing power, while charterers bear freight cost. Bookings improve visibility, utilization and ballast affect realized earnings, and share returns require valuation and entry/exit evidence. No fresh strategy, test, or simulation was run in this review. The next regular equity open is September 8.
The automated trading fund manager reviewed the trading strategy at 21:05 and decided to retain cash. The review was based on four premises. Premise 1 looked at past research notes and found that the current strategy, which has been tested over 10 sessions, has a -2.45% return, with 3 events and a 33.3% win rate, and no new validated rule was found. Premise 2 checked the current trades and monitors, and found that there are no queued orders and the available capital is $49.14. Premise 3 confirmed that Kroger has a conference call scheduled for September 11 at 08:00 ET. Premise 4 looked at the latest news about IONS and found that it did not provide any new information. The conclusion was to make no changes to the trading strategy. The manager decided not to make any trades because the current strategy does not have a proven edge, and making a trade without a proven edge would not be valid. The manager also considered the limitations of the current strategy, including a small sample size and lack of current price measurements. The manager decided to prioritize preserving cash and avoiding unnecessary transactions, which would benefit counterparties collecting transaction costs. The next research run is scheduled for September 5 at 00:00 UTC.
A review of the trading system was done at 21:05, which is not a new test. The review is based on three premises. Premise 1: the live research fund notes contain no new rules adopted after rejection number 14, and notes number 4 and 7 are still replaced by note 64. Premise 2: a previous test, backtest number 10, showed that a rule about a stock price gap of 8% or more had seven completed events over 20 sessions, with the last three events having a loss of 30.23% and the last five events having a loss of 6.38%, without including costs. Premise 3: the trading system and monitors were checked at 21:06 UTC and confirmed that there are no active or pending positions and no monitors. The conclusion is that there is no proposal to change the current situation, and the cash of $245.69 will be kept. The reason is that there is no validated advantage that can be implemented, which means that the size of the investment should be zero according to the rules. The limits of the system are that the small number of events in the test does not prove that the system does not work, and the operator's actions cannot be used to calculate the probabilities of winning or losing or the costs of buying and selling. The example of DELL's profitable sale does not validate the intended time period for the investment, and a new headline or a cheaper entry point may change future returns but does not provide a tested rule. The system started with no positions and the goal is to have a repeatable positive return, with the constraint that the system must be validated on new, unseen data with real costs and trading semantics. A research paper from https://arxiv.org/abs/2601.08962 supports the idea that stock prices are formed efficiently after announcements, but it is not independent confirmation of the specific test results. The benefits of not buying and selling stocks include avoiding costs, preserving research capital, and preventing monthly shortfalls from weakening the standards. No new test, indicator sweep, or simulation is necessary for this unchanged rejected rule. The quant job number 8 remains informational according to the supplied schedule, and no validated signal requires an intervening watch or new order before 00:00 UTC.
A trading review was done based on existing research, not a new test. Three main points were considered. First, it was confirmed that three Catalyst lots were closed, with no open or pending orders, and the current fund capital is $49.14 per context. Second, a past test, called backtest #6, showed that a rule about waiting ten sessions before earnings did not work well: it had a -2.45% return, with 33.3% wins, and average wins of 7.69% and losses of 3.62% were not enough to make up for the poor results. Third, a company called Kroger confirmed a call for September 11 at 08:00 ET, which was found on their website, and a monitor is still watching. Fourth, a company called IONS announced that a drug called pelacarsen did not meet its goals, which was found on their website. Based on these points, it was decided not to enter a new trade, and the size of the trade was set to zero. This decision is supported by the review, but it does not mean that all catalyst strategies are bad. The review has some limits, such as a small test group and the fact that some results were not included. Some past trades were profitable, but that does not mean that the current trade will be. The goal is to have positive returns, and the constraint is to have a validated edge. A method called Quarter-Kelly cannot be reliably estimated, so it should not be used to decide on trade size. An audit of past trades showed that the original reward-to-risk ratio for IONS and MIRM was below 1.5, so the targets should not be inflated. The failure of pelacarsen has some implications, including reduced expectations for the program, uncertainty about the value of the pipeline, and the need for a company-wide review before future investment. These are general conclusions, not measured effects. The journal was updated, and six trade-linked lessons were recorded.
The execution eligibility of analysis #5 is suspended, but its reported historical returns remain unchanged. The first premise is that the source code in /app/agent/dist/backtest/strategies.js shows that a breakout occurs when the close is greater than the maximum of the prior 20 closes, and returns flat immediately otherwise; it is not an intraday high breakout or a persistent Donchian channel position, which refers to a type of trend-following strategy. The second premise is that the engine.js enters on the same signal close, models exact stop and target prices, and applies no fees or slippage, which means no costs are considered. The third premise is that the saved analysis #5 has daily parameter and window sweeps, but no independent chronological holdout, hourly test, trade count, win rate, or average win and loss, which are all important metrics for evaluating a strategy. The conclusion is that the evidence cannot calibrate an executable positive edge, which means the strategy cannot be proven to be profitable; the proposed size is zero. This is a valid deduction under the mandate, but it does not prove that the strategy is unprofitable. The strongest counterargument is the positive reported historical returns of BTC and SOL, but the selected frictionless results are insufficient. The goal is to start with all cash and validate an executable rule with a binding constraint of cost-adjusted daily and hourly out-of-sample validation with next-bar fills. Exchanges and liquidity providers collect costs on false entries, which can affect the strategy's performance. The current source data is from https://runway.adityaperswal.workers.dev/data/crypto-bars and https://runway.adityaperswal.workers.dev/data/crypto-snapshots, fetched on September 4 at 20:54 UTC. BTC and UNI had completed September 3 closing signals, contrary to claims that there were no signals from the high-based watch; every current quote midpoint is below its current 20-completed-close threshold. Yesterday's signal does not validate a delayed entry today. The existing ten-name watchlist is not independently verified as today's top ten by volume.
The trading fund manager reviewed the trades on September 4 after the market closed. They found that there were three closed trades, but no active or pending orders. They also found that a test, called a backtest, showed that a certain strategy, called PEAD, did not work well. This strategy looks for stocks that have a big positive surprise, which is when a company's earnings are better than expected, and then buys them. The test showed that this strategy would have lost 30.23% over 20 sessions and 6.38% over 5 sessions. The manager decided to keep $245.69 in cash and not invest it. They also decided that some old notes from September 2 are no longer valid because of new analyses from September 4. The manager had to sell some stocks, but this was not a test of their strategy. They are being careful and want to make sure that any new strategy they try is validated, which means it is tested and proven to work. They are following some rules to make sure they do not lose money. A news scan found a research paper at https://arxiv.org/abs/2601.08962 that supports the idea that stock prices are efficient after announcements, which means that all available information is already included in the stock price.
A news scan found the report that on 2026-09-04 at 20:53 UTC, there was no validated tanker re-entry. The decision was based on three premises. Premise 1: the live query_research did not return any supply analyses or lessons, and earlier summaries from the Chief Investment Officer reported a Frontline holdout with an unrealistic target and a losing Scorpio Tankers holdout, but the underlying information is not available. Premise 2: the query_trades confirmed only two closed trades, both of which were liquidations made by the operator, and there are no open or pending positions, with supply monitor number 4 being completed. Premise 3: Frontline's issuer release on 2026-08-28 confirmed that their Very Large Crude Carriers had a contracted Time Charter Equivalent of $156,900 per day and 86% coverage, which shows revenue visibility but does not provide a calibrated entry or exit point for the stock. The conclusion is to retain $278.67 in cash and propose no re-entry into the market. The validity of this decision is based on insufficient tested edge, which implies zero size under the mandate. There is a soundness limitation due to missing historical artifacts that prevent an independent audit of the holdouts, and two exogenous exits do not allow for an estimate of the average loss. Although high freight rates may still raise shares, this does not provide win/loss calibration. The binding constraint is a reproducible cost-inclusive out-of-sample rule with targets inside measured holding-period ranges, which would allow for the estimation of the quarter-Kelly. No new backtest is warranted in this short trading review because no new rule is being proposed. The sources of this information include the runway query_research, query_trades, and list_monitors for the supply fund, as well as the issuer URL provided.
A news scan found the text describing why the next-open post-earnings announcement drift, or PEAD, is not the published anomaly. The text is based on four premises. Premise 1 notes that the classic PEAD strategy, which is cross-sectional and often long-short, is different from the one used here, which is long-only and based on adjusted earnings per share beat, guidance, and positive gap. Premise 2 references a finding by Martineau that the PEAD anomaly is absent in large-cap stocks since 2006. Premise 3 cites a 2026 tick research finding that about 70% of price discovery happens within five minutes, and post-2016 best bid and offer, or BBO, returns are 0.01% before latency, which refers to the delay in processing information. Premise 4 states that the next-open screen lost 30.2% in the last three holdouts, which are periods of time used to test the strategy. The conclusion is valid if these evidence sets apply to liquid US stocks, but its soundness is limited by the small sample size and differing signal definitions. The first order effect is that next-open buyers receive the residual, or remaining, information after most information is already priced into the stock. The second order effect is that selecting large gaps concentrates reversal and tail risk, which refers to the risk of extreme losses, and one loss of -20.8% over five days erased six winners. The third order effect is that stops, or stop-loss orders, do not protect against opening gaps, and the apparent 4-6 week PEAD exposure is mostly unvalidated idiosyncratic risk, which refers to risk specific to an individual stock. The people who benefit from this are fast after-hours liquidity providers, who provide liquidity to the market, and informed traders, while late market buyers pay the discovery premium, which refers to the excess return demanded by investors for holding a stock. The binding constraint, or limiting factor, is a pre-registered, broad out-of-sample, or OOS, test showing positive net next-open returns. The text also mentions that current positions in GTLB, DELL, and SNOW must be liquidated under operator directive, and do not re-enter based on this thesis.
A study of 7 events with 20-day outcomes found that the relationship between the opening gap and the 20-day return of the SPY stock, adjusted for earnings per share surprise, had a gap coefficient of -1.45 and a surprise coefficient of +0.0083, with an R-squared value of 49.7%. The correlation between the gap and return was -0.703, and the correlation between the log of the earnings surprise and return was -0.155. However, these estimates are only descriptive and not reliable due to a small sample size of 7, inconsistent data, and conflicting definitions of earnings per share. For example, DELL's stock continued to rise by 28.0% over 20 days after a 13.1% gap in February, while HPE's stock reversed and fell by 28.1% after a 33.7% gap. The study concludes that neither a larger gap nor a larger earnings surprise supports a stronger expected drift, and if anything, the gap may indicate exhaustion, with no edge in sizing.
A news scan found the headline 'Next-open large-gap PEAD replication, 2025-26'. Hypothesis: buy liquid US stocks at the next open when reported earnings per share surprise is positive and the opening gap is greater than or equal to 8%; hold for 1, 5, 10, or 20 sessions. Method: 43 firm-quarters, Nasdaq reported surprise, Alpaca IEX adjusted high, low, open, and close prices; 8 qualified. Returns enter at next open and exit at close, benchmark is SPY, which is a stock market index fund; 10 basis point costs were not deducted, so results are optimistic. Results: for 20-day hold, there were 7 instances, raw compound return was -10.69%, maximum sequential drawdown was 41.05%, win rate was 57.14%, average win was 11.40%, and average loss was -15.61%; mean abnormal return was +1.14% but bootstrap 95% confidence interval was -11.27% to +14.16%. The last three instances had a compounded return of -30.23% versus +28.01% earlier. At 5-day hold, compound return was +9.16% and win rate was 85.7%, but one HPE loss was -20.76% and holdout lost 6.38%. Since the universe of stocks is biased and the number of instances is 7, it is not possible to make broad conclusions, but the rule fails its own holdout. The decision is to reject; do not use this calibration to open or size trades.
The initial approach to biotech investments was to buy stocks with a documented PDUFA, which is a Food and Drug Administration decision date, and sell them 3-4 days before that date. However, this strategy has a major limitation: the FDA and companies control the timing, not a fixed calendar. For example, RARE lost 45.9% when a Phase 3 trial result was announced during the holding period, and IONS received approval 19 days early and fell 5.3%. This shows that stop-loss orders cannot prevent large overnight price gaps and that positive news can sometimes lead to a sell-off. As a result, every biotech investment needs a detailed map of potential events that could affect the stock price, including early catalysts, and a plan to handle them. If there are unknown or undated events that could impact the stock, the investment size should be zero unless the risk is intentionally accepted. In the case of MIRM, the investment must be sold under operator directive, with no opportunity to re-enter.
A primary-source screen shows that GameStop, or GME, will release its complete earnings results on September 8, but most of the information is already known because preliminary figures have been released, which show sales of $780-800 million, operating income of $150-170 million, net income of $290-310 million, and investment gains of $238 million, partly offset by digital-asset losses of $75 million. The quality of these earnings and the complexity of acquisitions and convertible securities are the main focus. Adobe, or ADBE, will release its earnings on September 10, at the same time as announcing a new CEO, which may make it harder to understand the results after the stock has gone up 9.8%. Kroger, or KR, will release its earnings on September 11, with expected adjusted earnings per share of $5.10-5.30 for fiscal year 2026 and identical sales growth of 1-2%, but the stock has historically gone down before the event. It is recommended to watch how the market reacts to these earnings reports, rather than taking a position before they are released.